Trials / Completed
CompletedNCT05965427
Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIV
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (actual)
- Sponsor
- NEAT ID Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This data collection study aims to describe and compare the outcomes of Mpox on people living with HIV (PLHIV) and HIV-negative individuals who are on pre-exposure prophylaxis (PrEP). The study also aims to identify risk factors for specific Mpox outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention | Study is retrospective data collection only |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2025-05-07
- Completion
- 2025-05-07
- First posted
- 2023-07-28
- Last updated
- 2025-08-13
- Results posted
- 2025-08-13
Locations
9 sites across 4 countries: France, Poland, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT05965427. Inclusion in this directory is not an endorsement.